6C47

ICD-11 MMS 2026-01

Disorders due to use of synthetic cathinones

Description

Disorders due to use of synthetic cathinones are characterised by the pattern and consequences of synthetic cathinone use. Synthetic cathinones (also known as ‘bath salts’) are synthetic compounds with stimulant properties related to cathinone found in the khat plant, Catha edulis. The use of synthetic cathinones is common in young populations in many countries. They may produce a range of disorders including Synthetic Cathinone Intoxication, Synthetic Cathinone Dependence and Synthetic Cathinone Withdrawal. Several synthetic cathinone-induced mental disorders are recognised.

Exclusions from above levels

  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Child codes

  • 6C47.0 – Episode of harmful use of synthetic cathinones
  • 6C47.1 – Harmful pattern of use of synthetic cathinones
  • 6C47.2 – Synthetic cathinone dependence
  • 6C47.3 – Synthetic cathinone intoxication
  • 6C47.4 – Synthetic cathinone withdrawal
  • 6C47.5 – Synthetic cathinone-induced delirium
  • 6C47.6 – Synthetic cathinone-induced psychotic disorder
  • 6C47.7 – Certain specified synthetic cathinone-induced mental or behavioural disorders
  • 6C47.Y – Other specified disorders due to use of synthetic cathinones
  • 6C47.Z – Disorders due to use of synthetic cathinones, unspecified

Sibling codes

  • 6C40 – Disorders due to use of alcohol
  • 6C41 – Disorders due to use of cannabis
  • 6C42 – Disorders due to use of synthetic cannabinoids
  • 6C43 – Disorders due to use of opioids
  • 6C44 – Disorders due to use of sedatives, hypnotics or anxiolytics
  • 6C45 – Disorders due to use of cocaine
  • 6C46 – Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
  • 6C48 – Disorders due to use of caffeine
  • 6C49 – Disorders due to use of hallucinogens
  • 6C4A – Disorders due to use of nicotine
  • 6C4B – Disorders due to use of volatile inhalants
  • 6C4C – Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
  • 6C4D – Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP)
  • 6C4E – Disorders due to use of other specified psychoactive substances, including medications
  • 6C4F – Disorders due to use of multiple specified psychoactive substances, including medications
  • 6C4G – Disorders due to use of unknown or unspecified psychoactive substances
  • 6C4H – Disorders due to use of non-psychoactive substances
  • 6C4Y – Other specified disorders due to substance use
  • 6C4Z – Disorders due to substance use, unspecified

Foundation entity

Disorders due to use of synthetic cathinones – http://id.who.int/icd/entity/1605818663

Allowed postcoordination axes

Part of: 06: Mental, behavioural or neurodevelopmental disorders